(Q35894678)

11 August 2017

1 reference

title

Should aggressive surgery ever be part of the management of small cell lung cancer? (English)

1 reference

11 August 2017

1

Thomas K Waddell

1 reference

11 August 2017

Frances A Shepherd

2

1 reference

11 August 2017

language of work or name

1 reference

1 May 2004

1 reference

11 August 2017

published in

Thoracic surgery clinics

1 reference

11 August 2017

volume

14

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

271-281

1 reference

The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Survival after resection of small cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Survival in small cell lung carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Results of operation without adjuvant therapy in the treatment of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Treatment of oat-cell carcinoma of bronchus by preoperative radiotherapy and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Pre-operative radiotherapy and surgery in the treatment of oat cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

An aggressive approach to marginally resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Adjuvant cancer chemotherapy after resection of carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

The incidence of second primary tumors in long-term survivors of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Second primary malignancies following diagnosis of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Second primary malignancies in small-cell lung cancer: a major consequence of modest success

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization. A study of 375 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Combined small-cell and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

The Prospect of Disease Control by Surgery Combined with Chemotherapy in Stage I and Stage II Small Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Influence of surgical resection prior to chemotherapy on the long-term results in small cell lung cancer. A study of 150 operable patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Small cell carcinoma of the lung--to operate or not? Surgical experience and results

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Long-Term Survivors in Resected and Nonresected Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

A prospective analysis of chemotherapy following surgical resection of clinical stage I-II small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Surgery in the management of small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Multimodality treatment for small cell bronchial carcinoma. Preliminary results of a prospective, multicenter trial. The ISC-Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Effect of initial resection of small-cell carcinoma of the lung: a review of Southwest Oncology Group Study 7628.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Treatment of small cell lung cancer by pneumonectomy and single course high dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

The Feasibility of Adjuvant Surgery in Limited-Stage Small Cell Carcinoma: A Prospective Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Surgery after initial chemotherapy for localized small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Postchemotherapy resection of residual tumor in limited stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

The role of surgery in the management of selected patients with small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Small cell lung cancer I--III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Induction chemotherapy for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900004-0

7 January 2021

10.1016/S1547-4127(04)00004-0

Identifiers

DOI

1 reference

11 August 2017

1 reference